Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001683168-24-007319
Filing Date
2024-10-23
Accepted
2024-10-23 14:10:57
Documents
1
Group Members
PETER E. DEUTSCH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G deutsch_13g.htm SC 13G 37898
  Complete submission text file 0001683168-24-007319.txt   39387
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89456 | Film No.: 241388829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 25 EAST POINT LANE OLD GREENWICH CT 06870
Business Address
Deutsch Peter E. (Filed by) CIK: 0001998610 (see all company filings)

Type: SC 13G